Biochips (Microarrays/Microfluidics) Global Market

Forecast to 2023

Biochips Global Market is estimated to be worth $17,851.1 million by 2023

IQ4I Research & Consultancy published a new report on Biochips Global Market
Forecast To 2023 This report analyzes and studies the overall market, major Drivers &
Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the
World.

IQ4Is Report Contains 121 market data tables and 77 figures spread through 404 pages
and an exhaustive TOC on Biochips Global Market, TECHNOLOGY (Microarrays,
Microfluidics); PRODUCTS(Instruments, Reagents & Consumables); APPLICATIONS
(Genomics, Proteomics, Drug Discovery, Diagnostics, Food & agricultural testing and
others); PRODUCTS (Instruments, Reagents and Software and Services); END-USERS
(Pharmaceutical & Biotech companies, Academic & Research laboratories, Diagnostic
laboratories, CROs and Others); REGIONAL (North America, Europe, Asia Pacific and Rest
of the World)]

Biochips are the miniaturized version of the lab tests that are organized on a compact
substrate which allows hundreds or thousands of the biochemical reactions to be executed.
Typical biochips surface area is no bigger than a fingernail but performs several of biological
reactions. Biochips provide abundance of applications like Gene expression, genotyping,
protein expression, and screening of new drugs, diagnosis of cancer and other diseases.

Biochips technologies are majorly differentiated into two types Microarrays and Microfluidics.
According to IQ4I estimation, the biochips global market is expected to reach $17,851.1
million by 2023 growing at a double digit CAGR. Increase in usage of biochips in cancer
diagnostics, biochips preference in personalized medicine, Widening application market of
biochips, increased government funding are contributing to the growth of biochips market.
However, high cost of biochips, lack of standardization, limited skilled personnel to work on
biochips, stringent regulations for the approval of biochip products are causing the market to
slow down.

The biochips market is segmented into technology, products, applications, end users and by
geography. Among two technologies microfluidics occupies major share in the global
technology market and is projected to grow at a high double digit CAGR during 2016-2023.
The products market is dominated by Reagents and Consumables, this segment accounts
for the major share and is estimated to grow at double digit CAGR.

The global biochips application segment is classified into Genomics, Proteomics, Drug
discovery, Diagnostics and other applications. Diagnostics segment is the largest and fastest

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Biochips (Microarrays/Microfluidics) Global Market

Forecast to 2023

growing segment among applications. In diagnostics, point of care diagnostics intended to

use portable simple test strips near the patient which in turn justified by the usage of
microfluidics. And also biochips especially microfluidics will play a major role in the treatment
of various diseases and therapy monitoring with personalized drug.

End-users of biochips market are classified into pharmaceutical & biotech companies,
Academic & research laboratories, Diagnostic laboratories, CROs (Contract & research
organizations) and others. Diagnostic laboratories commanded the largest share among the
end-users. Geographically, North America commanded the largest share in the Biochips
global market in 2016. Asia-Pacific with emerging countries representing huge growth
opportunities for the biochips market to flourish, the biochips market in this region is
estimated to grow at high double digit CAGR.

Advancements and newer technologies like portable inkjet printed microfluidic chips, 3D
printed organ-on-chips are revolutionizing biochips market. For instance, a biochip invented
by Worcester Polytechnic Institute (WPI) research scientists in October 2016 helps to trap
and identify metastatic cancer cells present in a small amount of blood from cancer patients.
Wound healing biochip is one of the emerging applications in recent days, which is
developed by Professor Peter Ertl at the TU WIEN University (Austria). This chip is simpler,
less expensive and highly accurate. It has microfluidic channels wherein, necessary
biological conditions including temperature, pressure and flow rates are being reproduced.
Qiagen (Germany) manufactures Human wound healing RT Profiler PCR array which
profiles the expression of 84 key genes.

The Biochips market is dominated by major players namely Danaher Corporation (U.S),
Abbott Laboratories (U.S), ThermoFisher Scientific (U.S), Illumina (U.S), Agilent
Technologies (U.S), Becton Dickinson (U.S), Bio-Rad laboratories (U.S) in which Danaher
occupies major shares. Further, the companies are acquiring other significant players in the
market to retain their leadership position in the market. For instance, in November 2016,
Danaher Corporation acquired Cepheid for approximately $4 billion and thus entered into
microfluidics market.

Major players in biochips market include Abbott laboratories (U.S), Agilent Technologies
(U.S.), Becton-Dickinson Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher
Corporation (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S), Illumina (U.S.),
PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.)

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Biochips (Microarrays/Microfluidics) Global Market

Forecast to 2023

Reasons for buying this report:

Analysis of the biochips global market by identifying various segments by technology,
products, applications, end-users and geography.
Revenue forecast of the biochips global market and strategic analysis of each
submarket with respect to segmental growth trends.
Analysis of the major market trends and factors driving or inhibiting the growth of the
biochips global market.
Revenue forecast of the biochips global market with respect to North America (U.S.
and others), Europe (U.K, Germany, France and Others), Asia-Pacific (Japan, China,
India and others) and the Rest of the World (RoW) (Brazil, Rest of Latin America and,
Middle East & Others).
Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
Country level analysis of microarrays and microfluidics technology, products and
applications.
Identification of key technology developments and innovations driving the market.
Profiles of major players in the biochips global market with details of their product
offerings, business strategies, SWOTs, upcoming technology, and supply chain
analysis.
Individual Market share analysis of microarrays and microfluidics and overall biochips
market share analysis
Established and Emerging players (112 companies) and their product offerings.

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Biochips (Microarrays/Microfluidics) Global Market

Forecast to 2023

FIGURE 1

BIOCHIPS GLOBAL MARKET SEGMENTATION

Biochips global market

By Technology By Products By By By
Application End-users Geography
Micro Micro Pharmaceutical North
Instruments Genomics
arrays fluidics & Biotech America
companies
DNA micro Reagents
PCR-on-a-chip Proteomics Academic &
arrays &Consumables Europe
Research
Protein Immunoassays- Software & laboratories
microarrays on-a-chip Services Drug Discovery Asia Pacific
Diagnostic
Tissue micro Electrophoresis laboratories
arrays -on-a-chip Diagnostics
ROW
CROs
Cell micro Flow cytometry
Food &
arrays -on-a-chip
agriculture
Others
Other micro
NGS-on-a-chip Others
arrays

Organ-on-chip

Others

IQ4I Research & Consultancy Pvt. Ltd. Page 4